Esomeprazole sodium and method for detecting impurity content in esomeprazole sodium for injection

A technology for esomeprazole sodium and a detection method is applied in the field of drug analysis, and can solve the problems of difficulty in evaluating the quality of esomeprazole, increasing adverse drug reactions, monitoring important impurities, and the like, Achieve the effect of good control, accurate quality control methods, and scientific detection methods

Active Publication Date: 2015-01-21
JIANGSU CHIA TAI FENGHAI PHARMA
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, because esomeprazole sodium is easy to introduce some process impurities in the production process, and it is easy to produce some degradation products in the process of freeze-drying and storage. Therefore, the content detection and impurity inspection methods in esomeprazole sodium and its injections are of great significance for controlling the quality of esomeprazole sodium and ensuring the clinical efficacy of esomeprazole sodium preparations
[0006] However, in the prior art, the quality control of esomeprazole sodium and esomeprazole sodium for injection usually adopts the method of detecting the content of esomeprazole sodium, and it is difficult to monitor its important impurities one by one. , it is difficult to evaluate the quality of esomeprazole, especially esomeprazole for injection

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Esomeprazole sodium and method for detecting impurity content in esomeprazole sodium for injection
  • Esomeprazole sodium and method for detecting impurity content in esomeprazole sodium for injection
  • Esomeprazole sodium and method for detecting impurity content in esomeprazole sodium for injection

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Embodiment 1 Determination of impurities in esomeprazole sodium by high performance liquid chromatography

[0027] Determination according to high performance liquid phase method (Chinese Pharmacopoeia 2010 edition two appendix V D)

[0028] Chromatographic conditions and system suitability test Octadecylsilane bonded silica gel was used as filler. Mobile phase: mobile phase A is an aqueous solution containing 1.4 g of disodium hydrogen phosphate dodecahydrate per 1 L, adjusted pH to 7.4 with phosphoric acid, mobile phase B is acetonitrile, and performs gradient elution. Take esomeprazole sodium and impurity 4 respectively and dilute with the initial mobile phase to make a mixed solution with a concentration of 0.02mg / ml, as a system suitability solution. Take 10 μl of the system suitability solution and inject it into the liquid chromatograph, the peak order is impurity 4, esomeprazole, and the separation degree of impurity 4 and esomeprazole should meet the requireme...

Embodiment 2

[0036] Embodiment 2 Determination of impurities in esomeprazole sodium by high performance liquid chromatography

[0037] Determination according to high performance liquid phase method (Chinese Pharmacopoeia 2010 edition two appendix V D)

[0038] Chromatographic conditions and system suitability test Octadecylsilane bonded silica gel was used as filler. Mobile phase: mobile phase A is an aqueous solution containing 1.4 g of disodium hydrogen phosphate dodecahydrate per 1 L, adjusted pH to 7.6 with phosphoric acid, mobile phase B is methanol, and gradient elution is performed. Take esomeprazole sodium and impurity 4 respectively and dilute with the initial mobile phase to make a mixed solution with a concentration of 0.02mg / ml, as a system suitability solution. Take 10 μl of the system suitability solution and inject it into the liquid chromatograph, the peak order is impurity 4, esomeprazole, and the separation degree of impurity 4 and esomeprazole should meet the requireme...

Embodiment 3

[0046] Embodiment 3 Determination of impurities in esomeprazole sodium by high performance liquid chromatography

[0047] Determination according to high performance liquid phase method (Chinese Pharmacopoeia 2010 edition two appendix V D)

[0048] Chromatographic conditions and system suitability test Octadecylsilane bonded silica gel was used as filler. Mobile phase: mobile phase A is an aqueous solution containing 1.4 g of disodium hydrogen phosphate dodecahydrate per 1 L, adjusted pH to 7.8 with phosphoric acid, mobile phase B is acetonitrile, and performs gradient elution. Take esomeprazole sodium and impurity 4 respectively and dilute with the initial mobile phase to make a mixed solution with a concentration of 0.02mg / ml, as a system suitability solution. Take 10 μl of the system suitability solution and inject it into the liquid chromatograph, the peak order is impurity 4, esomeprazole, and the separation degree of impurity 4 and esomeprazole should meet the requireme...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides esomeprazole sodium and a method for detecting content of the esomeprazole sodium for injection. A chromatographic column, using octadecyl silane bonded silica gel or octo-alkyl silane bonded silica gel as a filling agent, implements the gradient elution with mixed solvent of an organic phase and a water phase as a mobile phase to measure the esomeprazole sodium and the content of eight impurities thereof. The method is simple in process and low in cost, and adopts the gradient elution method to measure the esomeprazole sodium and the content of eight important impurities thereof; the detection method is scientific, reasonable and objective, so that the quality of the esomeprazole sodium can be preferably controlled.

Description

technical field [0001] The invention belongs to the field of drug analysis, in particular to a method for detecting impurity content in proton pump inhibitor esomeprazole sodium and esomeprazole sodium for injection. Background technique [0002] Esomeprazole sodium (Esomeprazole Sodium, S-5-methoxy-2{[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl}-1H -benzimidazole sodium) is a powerful free radical scavenger and antioxidant, its molecular formula is C 17 h 12 N 3 NaO 3 S, molecular weight 367.4, structural formula: [0003] [0004] Esomeprazole sodium is the drug of choice for the treatment of acid-related diseases such as peptic ulcer and gastroesophageal reflux disease. As a single isomer of omeprazole, that is, (S)-isomer, it has higher bioavailability and more consistent pharmacokinetics, which increases the drug reaching the proton pump, and its acid suppression effect is better than that of Other proton pump inhibitors (PPIs). [0005] Esomeprazole sod...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): G01N30/02G01N30/34
Inventor 赵文惠叶海英杜柳辉朱勇
Owner JIANGSU CHIA TAI FENGHAI PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products